• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Artificial Intelligence Enabled Lifestyle Medicine in Diabetes Care: A Narrative Review.人工智能助力糖尿病护理中的生活方式医学:一项叙述性综述。
Am J Lifestyle Med. 2025 Jul 17:15598276251359185. doi: 10.1177/15598276251359185.
2
The impact of artificial intelligence on the endoscopic assessment of inflammatory bowel disease-related neoplasia.人工智能对炎症性肠病相关肿瘤内镜评估的影响。
Therap Adv Gastroenterol. 2025 Jun 23;18:17562848251348574. doi: 10.1177/17562848251348574. eCollection 2025.
3
Research status, hotspots and perspectives of artificial intelligence applied to pain management: a bibliometric and visual analysis.人工智能应用于疼痛管理的研究现状、热点与展望:一项文献计量学与可视化分析
Updates Surg. 2025 Jun 28. doi: 10.1007/s13304-025-02296-w.
4
Integrating artificial intelligence in healthcare: applications, challenges, and future directions.将人工智能整合到医疗保健中:应用、挑战及未来方向。
Future Sci OA. 2025 Dec;11(1):2527505. doi: 10.1080/20565623.2025.2527505. Epub 2025 Jul 4.
5
Gaps in Artificial Intelligence Research for Rural Health in the United States: A Scoping Review.美国农村卫生人工智能研究的差距:一项范围综述
medRxiv. 2025 Jun 27:2025.06.26.25330361. doi: 10.1101/2025.06.26.25330361.
6
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.深度学习方法在自身免疫性大疱性疾病中的直接免疫荧光模式识别。
Br J Dermatol. 2024 Jul 16;191(2):261-266. doi: 10.1093/bjd/ljae142.
7
Applications of Artificial Intelligence and Machine Learning in Prediabetes: A Scoping Review.人工智能和机器学习在糖尿病前期的应用:一项范围综述
J Diabetes Sci Technol. 2025 Jul 8:19322968251351995. doi: 10.1177/19322968251351995.
8
Perspectives of Health Care Professionals on the Use of AI to Support Clinical Decision-Making in the Management of Multiple Long-Term Conditions: Interview Study.医疗保健专业人员对使用人工智能支持多种慢性病管理中临床决策的看法:访谈研究
J Med Internet Res. 2025 Jul 4;27:e71980. doi: 10.2196/71980.
9
Harnessing Artificial Intelligence in Lifestyle Medicine: Opportunities, Challenges, and Future Directions.在生活方式医学中利用人工智能:机遇、挑战与未来方向。
Cureus. 2025 Jun 8;17(6):e85580. doi: 10.7759/cureus.85580. eCollection 2025 Jun.
10
Health Care Professionals' Experience of Using AI: Systematic Review With Narrative Synthesis.医疗保健专业人员使用人工智能的体验:系统评价与叙事综合。
J Med Internet Res. 2024 Oct 30;26:e55766. doi: 10.2196/55766.

本文引用的文献

1
Proteomics-based mortality prediction modeling in type 2 diabetes: new promise for personalized treatment and prevention.基于蛋白质组学的2型糖尿病死亡率预测模型:个性化治疗与预防的新希望
BMC Med. 2025 Jan 21;23(1):17. doi: 10.1186/s12916-024-03803-3.
2
Determinants of developing cardiovascular disease risk with emphasis on type-2 diabetes and predictive modeling utilizing machine learning algorithms.心血管疾病风险发展的决定因素,重点关注2型糖尿病以及利用机器学习算法的预测模型。
Medicine (Baltimore). 2024 Dec 6;103(49):e40813. doi: 10.1097/MD.0000000000040813.
3
Artificial intelligence-based body composition analysis using computed tomography images predicts both prevalence and incidence of diabetes mellitus.基于人工智能利用计算机断层扫描图像进行的身体成分分析可预测糖尿病的患病率和发病率。
J Diabetes Investig. 2025 Feb;16(2):272-284. doi: 10.1111/jdi.14365. Epub 2024 Nov 22.
4
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants.全球糖尿病患病率和治疗趋势 1990 年至 2022 年:基于 14100 万参与者的 1108 项人群代表性研究的汇总分析。
Lancet. 2024 Nov 23;404(10467):2077-2093. doi: 10.1016/S0140-6736(24)02317-1. Epub 2024 Nov 13.
5
Effectiveness of behaviour change techniques in lifestyle interventions for non-communicable diseases: an umbrella review.行为改变技术在非传染性疾病生活方式干预中的有效性:伞式综述。
BMC Public Health. 2024 Nov 7;24(1):3082. doi: 10.1186/s12889-024-20612-8.
6
Digital Twin in Managing Hypertension Among People With Type 2 Diabetes: 1-Year Randomized Controlled Trial.数字孪生技术在2型糖尿病患者高血压管理中的应用:一项为期1年的随机对照试验。
JACC Adv. 2024 Aug 14;3(9):101172. doi: 10.1016/j.jacadv.2024.101172. eCollection 2024 Sep.
7
An explainable Artificial Intelligence software system for predicting diabetes.一种用于预测糖尿病的可解释人工智能软件系统。
Heliyon. 2024 Aug 10;10(16):e36112. doi: 10.1016/j.heliyon.2024.e36112. eCollection 2024 Aug 30.
8
Integrating Automation, Interactive Visualization, and Unsupervised Learning for Enhanced Diabetes Management.集成自动化、交互式可视化和无监督学习以增强糖尿病管理。
Stud Health Technol Inform. 2024 Aug 22;316:1699-1703. doi: 10.3233/SHTI240750.
9
Unlocking Potential: Personalized Lifestyle Therapy for Type 2 Diabetes Through a Predictive Algorithm-Driven Digital Therapeutic.释放潜力:通过预测算法驱动的数字疗法实现2型糖尿病的个性化生活方式治疗。
J Diabetes Sci Technol. 2024 Jul 30:19322968241266821. doi: 10.1177/19322968241266821.
10
SynthA1c: Towards Clinically Interpretable Patient Representations for Diabetes Risk Stratification.合成糖化血红蛋白(SynthA1c):迈向用于糖尿病风险分层的可临床解释的患者表征
Predict Intell Med. 2023 Oct;14277:46-57. doi: 10.1007/978-3-031-46005-0_5.

人工智能助力糖尿病护理中的生活方式医学:一项叙述性综述。

Artificial Intelligence Enabled Lifestyle Medicine in Diabetes Care: A Narrative Review.

作者信息

González-Rivas Juan P, Seyedi Seyed Arsalan, Mechanick Jeffrey I

机构信息

Departments of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA (JPGR).

Research Department, Foundation for Clinic, Public Health, and Epidemiological Research of Venezuela (FISPEVEN), Caracas, Venezuela (JPGR).

出版信息

Am J Lifestyle Med. 2025 Jul 17:15598276251359185. doi: 10.1177/15598276251359185.

DOI:10.1177/15598276251359185
PMID:40687630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12274213/
Abstract

To examine the applications of artificial intelligence (AI) in lifestyle medicine focused on diabetes care as a narrative review. Relevant keywords were identified and searched using PubMed to find relevant studies on AI in diabetes lifestyle management. AI applications in diabetes care were divided into four primary categories: 1- predictive models for diabetes risk and complications, which can utilize random forest and deep learning, demonstrating high accuracy rates (>80%); 2- personalized lifestyle recommendations, which can utilize clustering techniques and causal forest analysis to adapt interventions, leading to enhanced glycemic control and weight reduction; 3- remote monitoring and self-management tools, which can utilize digital twin technology and machine learning for behavior modeling, showing improved patient adherence and clinical results; and 4- clinical decision support systems, which assess various data sources for enhanced diagnosis and treatment suggestions. AI technologies show significant potential in improving diabetes care through multiple modalities that offer scalable cost-effective solutions, improved patient outcomes, and more efficient resource distribution.

摘要

作为一篇叙述性综述,探讨人工智能(AI)在以糖尿病护理为重点的生活方式医学中的应用。通过使用PubMed识别并搜索相关关键词,以查找关于AI在糖尿病生活方式管理方面的相关研究。AI在糖尿病护理中的应用主要分为四类:1-糖尿病风险和并发症的预测模型,可利用随机森林和深度学习,显示出较高的准确率(>80%);2-个性化生活方式建议,可利用聚类技术和因果森林分析来调整干预措施,从而改善血糖控制和减轻体重;3-远程监测和自我管理工具,可利用数字孪生技术和机器学习进行行为建模,显示出患者依从性和临床效果的改善;4-临床决策支持系统,评估各种数据源以提供增强的诊断和治疗建议。AI技术通过多种方式在改善糖尿病护理方面显示出巨大潜力,这些方式提供了可扩展的成本效益解决方案、改善的患者预后以及更有效的资源分配。